OREX

Orexigen Therapeutics, Inc. News Headlines

$5.57
*  
0.10
1.76%
Get OREX Alerts
*Delayed - data as of Jan. 28, 2015 13:00 ET  -  Find a broker to begin trading OREX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    OREX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Gallup Says Obesity Rates Climb Again - Can Anti-Obesity Companies Cash In?
1/28/2015 11:49:00 AM - Seeking Alpha


Arena - Flat Scripts Is Not A Good Start To 2015
1/27/2015 5:15:00 PM - Seeking Alpha


Contrave Scripts Continue Increases For Orexigen
1/27/2015 3:33:00 PM - Seeking Alpha


What Investors Should Do About Imminent Obesity Drug Approvals In Europe
1/27/2015 8:38:00 AM - Seeking Alpha


Newly Approved Weight Loss Method Works by Tricking Your Brain
1/25/2015 12:02:02 PM - Motley Fool


Arena's Belviq Prescriptions Fall: More Publicity Is Needed
1/23/2015 2:17:00 PM - Seeking Alpha


Novo Nordisk Receives Positive Opinion In Europe On Obesity Treatment
1/23/2015 12:32:00 PM - Seeking Alpha


Orexigen Scripts Continue Impressive Track
1/21/2015 2:00:00 PM - Seeking Alpha


News Flash: The Endocrine Society Recommends Weight Loss Medications
1/21/2015 11:15:00 AM - Seeking Alpha


Forget Pills! Could This Device Put an End to Obesity in America?
1/17/2015 7:21:03 AM - Motley Fool


Orexigen Therapeutics, Inc. (OREX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
1/16/2015 7:00:00 AM - Investopedia


A Deeper Look At Arena's Belviq Pricing
1/12/2015 3:02:00 PM - Seeking Alpha


Orexigen's Contrave May Have Pricing Competition
1/12/2015 9:13:00 AM - Seeking Alpha


Sales Of Arena's Belviq Close Out 2014 - What Will 2015 Bring?
1/9/2015 2:49:00 PM - Seeking Alpha


Arena Investors Should Watch New Pricing Of Belviq Closely
1/9/2015 12:20:00 PM - Seeking Alpha


Why VIVUS, Inc. Stock Descended 14% in December
1/9/2015 9:03:01 AM - Motley Fool


Arena Pharmaceuticals Inc.'s Phase 1 Data is Worth $550 Million!?
1/8/2015 4:38:02 PM - Motley Fool


Why Arena Pharmaceuticals, Inc. Stock Slumped 17% in December
1/6/2015 8:03:02 AM - Motley Fool


Anticipated FDA Approval Eludes Enteromedics
1/5/2015 12:21:00 PM - Seeking Alpha


Sell EnteroMedics And Step To The Sidelines
12/30/2014 12:25:00 PM - Seeking Alpha


Can High Priced Novo Nordisk Anti-Obesity Injection Make It?
12/29/2014 1:30:00 PM - Seeking Alpha


The Obesity Treatment Market Could Finally Achieve Some Of Its Potential In 2015
12/29/2014 1:24:00 PM - Seeking Alpha


Arena - Belviq Advertsing Closes Out Year With Big Push
12/29/2014 1:13:00 PM - Seeking Alpha


Is Vivus Headed Towards An Unfortunate Ending?
12/27/2014 8:27:00 AM - Seeking Alpha


3 Stocks Poised for Eye-Popping Gains in 2015
12/27/2014 7:27:04 AM - Motley Fool